UniSa - IRIS Institutional Research Information System

SABBATINO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.798
NA - Nord America 3.994
EU - Europa 1.933
SA - Sud America 781
AF - Africa 109
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.881
HK - Hong Kong 3.863
SG - Singapore 1.342
BR - Brasile 611
IT - Italia 534
VN - Vietnam 488
CN - Cina 481
RU - Federazione Russa 297
DE - Germania 273
FR - Francia 160
TR - Turchia 117
IN - India 106
IE - Irlanda 105
FI - Finlandia 102
GB - Regno Unito 77
KR - Corea 77
AR - Argentina 76
SE - Svezia 76
UA - Ucraina 76
AT - Austria 54
CA - Canada 51
NL - Olanda 48
ID - Indonesia 46
JP - Giappone 42
ZA - Sudafrica 41
BD - Bangladesh 40
MX - Messico 36
IQ - Iraq 33
PL - Polonia 31
ES - Italia 28
CZ - Repubblica Ceca 24
EC - Ecuador 22
PK - Pakistan 20
CO - Colombia 17
SA - Arabia Saudita 17
UZ - Uzbekistan 17
CL - Cile 13
MY - Malesia 13
PH - Filippine 12
PY - Paraguay 12
MA - Marocco 11
NP - Nepal 11
TN - Tunisia 11
VE - Venezuela 11
AL - Albania 10
AU - Australia 9
AZ - Azerbaigian 9
IL - Israele 9
LT - Lituania 9
KE - Kenya 8
PE - Perù 8
EG - Egitto 7
TH - Thailandia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
JM - Giamaica 6
JO - Giordania 6
KG - Kirghizistan 6
DZ - Algeria 5
GR - Grecia 5
OM - Oman 5
ET - Etiopia 4
LB - Libano 4
NZ - Nuova Zelanda 4
PA - Panama 4
XK - ???statistics.table.value.countryCode.XK??? 4
BG - Bulgaria 3
BH - Bahrain 3
CH - Svizzera 3
IR - Iran 3
RO - Romania 3
AM - Armenia 2
AO - Angola 2
BJ - Benin 2
BN - Brunei Darussalam 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GM - Gambi 2
HN - Honduras 2
LY - Libia 2
MD - Moldavia 2
MM - Myanmar 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
TZ - Tanzania 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
Totale 13.613
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.860
Singapore 649
San Jose 581
Dallas 379
Ann Arbor 377
Ashburn 305
Chandler 304
Princeton 274
Munich 192
Council Bluffs 151
Ho Chi Minh City 132
Naples 125
Lauterbourg 122
The Dalles 122
Beijing 114
Hanoi 114
Dublin 100
Dong Ket 91
Izmir 91
Jacksonville 89
Los Angeles 81
Moscow 75
Wilmington 69
Houston 58
Andover 56
New York 56
São Paulo 54
Pellezzano 52
Nuremberg 45
Helsinki 44
Tokyo 37
Salerno 36
Turku 34
Vienna 33
Nanjing 32
Santa Clara 32
Woodbridge 30
Boardman 29
Warsaw 28
Orem 27
Brno 23
Denver 23
Fisciano 23
Haiphong 22
Poplar 20
Fairfield 19
Amsterdam 18
Nanchang 18
Pune 18
Rio de Janeiro 18
Atlanta 17
Chennai 17
Brooklyn 16
Changsha 16
Frankfurt am Main 16
Boston 15
Columbus 15
Johannesburg 15
San Francisco 15
Tashkent 15
Toronto 15
Biên Hòa 14
Brasília 14
Milan 14
Montreal 14
Norwalk 14
Chicago 13
Da Nang 13
Manchester 13
Baghdad 12
Mumbai 12
Paris 12
Phoenix 12
Sarno 12
Seattle 12
Shanghai 12
Lappeenranta 11
Mexico City 11
Quito 11
Seoul 11
Stockholm 11
Belo Horizonte 10
Jakarta 10
Baku 9
Cape Town 9
Curitiba 9
Goiânia 9
Tel Aviv 9
Baronissi 8
Campinas 8
Guarulhos 8
Istanbul 8
Jiaxing 8
Kathmandu 8
Ribeirão Preto 8
Rome 8
San Diego 8
Bogotá 7
Buenos Aires 7
Charlotte 7
Totale 9.860
Salva come PNG Salva come JPEG
Nome #
Cytopathological differential diagnosis of malignant tumor cells in the cerebrospinal fluid: A retrospective analysis 608
Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy 604
Prior Anti-Angiogenic TKI-Based Treatment as Potential Predisposing Factor to Nivolumab-Mediated Recurrent Thyroid Disorder Adverse Events in mRCC Patients: A Case Series 529
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors 509
Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers 470
KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies 420
Abstract 3132: Single nucleotide polymorphisms (SNPs) in PD-L1 as predictive biomarkers for checkpoint inhibitor based-immunotherapy in caucasian patients with advanced NSCLC 315
The Current and Future Impact of Lymph Node Fine-Needle Aspiration Cytology on Patient Care 249
Evaluation of Potential Predictive Biomarkers for Defining Brain Radiotherapy Efficacy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Case Report and a Narrative Review 240
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 237
Proceedings of the XXII National Conference of the Italian Society of Cytometry GIC, October 4–8, 2005, San Bendetto del Tronto (AP), Italy 192
rs822336 as a predictive biomarker for anti-PD-1/PD-L1 immunotherapy in advanced NSCLC: Unraveling molecular mechanisms 191
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 182
Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma 146
Antitumor activity of BRAF inhibitor and IFN×alpha; Combination in BRAF-mutant melanoma 144
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer 138
Combined fine needle aspiration cytology and core needle biopsy in the same setting: A two-years' experience 137
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC 137
Abstract 3639: Combinatorial therapy for triple negative breast cancer 135
Abstract 3703: PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation 131
Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells 129
597 IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 129
Inhibition of NF-kB activity potentiates ionizing radiation and cisplatin induced cell killing of anaplastic thyroid carcinoma cells AACR Meeting Abstracts, Apr 2006; 2006: 1038. 127
Cell growth-inhibition and cell cycle perturbations induced by a new synthetic iminoquinone, 5H-pyridophenoxazin-5-one, in human breast carcinoma cell lines. 126
rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in advanced cancer patients treated with anti-PD-1/PD-L1 therapy 120
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2011. September 10-14, 2011. Munich, Germany 119
The farnesyltransferase inhibitor R115777 (Zanestra) synergizes with ionizing radiation in inducing cell cycle perturbation and growth inhibition of human epidermoid head and neck cancer cells. 115
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2010. October 2-6, 2010. Valencia, Spain 115
Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients 113
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy 111
Abstract 4741: Inhibition of TNBC cell growth by CSPG4-specific mAb 225.28 with a Sonic Hedgehog pathway inhibitor 111
An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy 110
Blocking the formation of radiation-induced breast cancer stem cells 106
Ipilimumab in the treatment of metastatic melanoma: Management of adverse events 105
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches 104
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram 104
XXV Conferenza Nazionale di Citometria: CELL GROWTH INHIBITION AND CELL CYCLE PERTURBATIONS INDUCED BY A NEW SYNTHETIC IMINOQUINONE, 5H-PYRIDOPHENOXAZIN-5-ONE, IN HUMAN BREAST CARCINOMA CELL LINES 104
Multidisciplinary approach to patient with malignant melanoma 103
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma 102
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 102
PD-L1 Dysregulation in COVID-19 Patients 101
Counteracting resistance to treatments in solid tumors. 100
Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review 99
"Idealized" vs. "true" learning curves: The case of laparoscopic liver resection 97
Identification of Drug Interaction Adverse Events in Patients with COVID-19: A Systematic Review 97
Immune Checkpoint Inhibitors in Melanoma and HIV Infection 96
PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation. 96
Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma 94
Epigenetic control of gene expression: Potential implications for cancer treatment 94
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 94
Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase i inhibitor or radiation 93
XXV Conferenza Nazionale di Citometria: INHIBITION OF POLY (ADP-RIBOSE) POLYMERASE SYNERGIZES WITH THE DNA-TOPOISOMERASE-1-INHIBITOR, TOPOTECAN, AND RADIATION IN HUMAN GLIOBLASTOMA CELL LINE 91
The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology 90
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 88
Surgical Treatment, Rehabilitative Approaches and Functioning Assessment for Patients Affected by Breast Cancer-Related Lymphedema: A Comprehensive Review 87
Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice 86
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature 86
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients 85
Effect of tocilizumab in reducing the mortality rate in covid-19 patients: A systematic review with meta-analysis 84
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 83
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC 82
P.1.159: REPEATED LOCO-REGIONAL TREATMENTS: HIGH SURVIVAL RATES IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA HIGHLY COMPLIANT TO SCHEDULED FOLLOW-UP 82
Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors 82
Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives 82
Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study 81
Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy? 81
PD-L1 and HLA class i antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma 80
Harnessing host innate immunity may combat acquired resistance to BRAFi 79
P.1.112: IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 79
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma 79
Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation 76
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation 75
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19 74
Testing egfr with idylla on cytological specimens of lung cancer: A review 74
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells 73
Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy, Cancer Initiating Cells and Disease Recurrence 72
The prognostic role of p53 mutations in metastatic colorectal cancer: A systematic review and meta-analysis 71
Diagnosis of Langerhans cell histiocytosis on cytological examination of cerebrospinal fluid: Report of the first case 71
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives 71
Variability in immune infiltrates and HLA expression in cholangiocarcinoma 71
Emerging BRAF inhibitors for melanoma 71
Advancing the integration of biosignal-based automated pain assessment methods into a comprehensive model for addressing cancer pain 71
Ki67 in Gleason Pattern 3 as a Marker of the Presence of Higher-Grade Prostate Cancer 68
Melanoma initiating cells: where do we stand? 67
P.1.279: ADVANCED HCC ABLATION AFTER DOWSTAGING WITH SORAFENIB 67
Tissue micro arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma 67
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer 66
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors 66
Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells 66
Monoclonal antibody-based immunotherapy of ovarian cancer: Targeting ovarian cancer cells with the B7-H3-specific mAb 376.96 64
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors 63
The ratio of grzb+ − foxp3+ over cd3+ t cells as a potential predictor of response to nivolumab in patients with metastatic melanoma 62
Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma 60
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 58
PHH3 immunostaining: a novel prognostic biomarker in pancreatic neuroendocrine tumors 56
Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy 54
Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study 54
Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review 54
Genetic evolution of T-cell resistance in the course of melanoma progression 54
Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors 53
Totale 12.586
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021128 0 0 0 0 0 0 0 0 0 0 20 108
2021/2022462 7 0 2 1 22 5 2 19 79 50 66 209
2022/2023752 77 80 68 128 55 144 1 48 98 1 42 10
2023/2024555 41 42 37 37 37 59 44 29 35 37 29 128
2024/20251.792 44 17 28 66 90 195 322 138 335 141 198 218
2025/20269.043 792 2.229 1.769 681 741 432 977 233 488 646 55 0
Totale 13.916